12 Aug 2026
Mitigating breast cancer with intratumoral in situ pH-responsive abemaciclib-loaded novasome hydrogelPublisher siteJournal of drug targeting, Advanced Breast Cancer Therapies
UniversitiesMary Girgis Shahataa
Active, last published 2026
In genomics, phytochemicals, and oxidative stress
Mary Girgis
Shahataa
Scholar“Research focused on Genomics, phytochemicals, and oxidative stress and adjacent fields.”
Beni-Suef University
Claim Your Profile6
H-index
121
Citations
Mary has not officially claimed their profile. If you are Mary, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ary Girgis Shahataa is a researcher working on Genomics, phytochemicals, and oxidative stress. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mary's work has been cited 121 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Genomics, phytochemicals, and oxidative stress×3Nanoparticle-Based Drug Delivery×2Liver Disease Diagnosis and Treatment×2Advanced Drug Delivery Systems×2Analytical Methods in Pharmaceuticals×2
04 · Where I am
Affiliations
Affiliation on published researchBeni-Suef UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works20 Jun 2026
Retraction notice to “Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways” [Int. Immunopharmacol. 140 (2024) 112904]Publisher siteInternational Immunopharmacology, Genomics, phytochemicals, and oxidative stress
8 Nov 2024
Corrigendum to “Combined sulforaphane and β-sitosterol mitigate against olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways” [Int. Immunopharmacol. 140 (2024) 112904]Publisher siteInternational Immunopharmacology, Genomics, phytochemicals, and oxidative stress
7 Aug 20247cites
Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathwaysPublisher siteInternational Immunopharmacology, Genomics, phytochemicals, and oxidative stress
6 Jul 2024
Retraction notice to “Vitamin E protects against gabapentin-induced chronic hepatic and renal damage associated with the inhibition of apoptosis and tissue injury in rats” [Life Sci. 267 (2021) 118940]Publisher siteLife Sciences, Vitamin C and Antioxidants Research
18 Apr 202422cites
In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes‐accelerated atherosclerosisPublisher siteJournal of Drug Delivery Science and Technology, Receptor Mechanisms and Signaling
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mary?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you